These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 29956027

  • 1. Prospective study of relevance of 123I-MIBG myocardial scintigraphy and clonidine GH test to distinguish Parkinson's disease and multiple system atrophy.
    Alves Do Rego C, Namer IJ, Marcel C, Lefebvre F, Lagha-Boukbiza O, Renaud M, Tranchant C, Anheim M.
    J Neurol; 2018 Sep; 265(9):2033-2039. PubMed ID: 29956027
    [Abstract] [Full Text] [Related]

  • 2. 131I-MIBG myocardial scintigraphy for differentiation of Parkinson's disease from multiple system atrophy or essential tremor in Chinese population.
    Yang T, Wang L, Li Y, Cheng M, Jiao J, Wang Q, Guo H.
    J Neurol Sci; 2017 Feb 15; 373():48-51. PubMed ID: 28131225
    [Abstract] [Full Text] [Related]

  • 3. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
    Chung EJ, Lee WY, Yoon WT, Kim BJ, Lee GH.
    Mov Disord; 2009 Aug 15; 24(11):1650-5. PubMed ID: 19514077
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis.
    Treglia G, Stefanelli A, Cason E, Cocciolillo F, Di Giuda D, Giordano A.
    Clin Neurol Neurosurg; 2011 Dec 15; 113(10):823-9. PubMed ID: 21962800
    [Abstract] [Full Text] [Related]

  • 6. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M, Hayashi M, Hirai S.
    Rinsho Shinkeigaku; 1997 Jun 15; 37(6):476-82. PubMed ID: 9366173
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Abnormal cardiac [(123)I]-meta-iodobenzylguanidine uptake in multiple system atrophy.
    Nagayama H, Ueda M, Yamazaki M, Nishiyama Y, Hamamoto M, Katayama Y.
    Mov Disord; 2010 Aug 15; 25(11):1744-7. PubMed ID: 20645402
    [Abstract] [Full Text] [Related]

  • 10. Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography.
    Lee EA, Kim BJ, Lee WY.
    Mov Disord; 2002 Nov 15; 17(6):1242-7. PubMed ID: 12465063
    [Abstract] [Full Text] [Related]

  • 11. Pupillary autonomic dysfunction in multiple system atrophy and Parkinson's disease: an assessment by eye-drop tests.
    Yamashita F, Hirayama M, Nakamura T, Takamori M, Hori N, Uchida K, Hama T, Sobue G.
    Clin Auton Res; 2010 Jun 15; 20(3):191-7. PubMed ID: 20127386
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis.
    Orimo S, Suzuki M, Inaba A, Mizusawa H.
    Parkinsonism Relat Disord; 2012 Jun 15; 18(5):494-500. PubMed ID: 22321865
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy.
    Braune S, Reinhardt M, Schnitzer R, Riedel A, Lücking CH.
    Neurology; 1999 Sep 22; 53(5):1020-5. PubMed ID: 10496261
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Levodopa challenge test and (123) I-metaiodobenzylguanidine scintigraphy for diagnosing Parkinson's disease.
    Asayama S, Wate R, Kaneko S, Asayama T, Oki M, Tsuge A, Nagashima M, Morita J, Nakamura S, Nakamura M, Nishii M, Fujita K, Saito A, Nakano S, Ito H, Kusaka H.
    Acta Neurol Scand; 2013 Sep 22; 128(3):160-5. PubMed ID: 23410225
    [Abstract] [Full Text] [Related]

  • 18. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
    Saiki S, Hirose G, Sakai K, Kataoka S, Hori A, Saiki M, Kaito M, Higashi K, Taki S, Kakeshita K, Fujino S, Miaki M.
    J Neurol Sci; 2004 May 15; 220(1-2):105-11. PubMed ID: 15140615
    [Abstract] [Full Text] [Related]

  • 19. Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease?
    Tranchant C, Guiraud-Chaumeil C, Echaniz-Laguna A, Warter JM.
    J Neurol; 2000 Nov 15; 247(11):853-6. PubMed ID: 11151417
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease.
    Umemura A, Oeda T, Hayashi R, Tomita S, Kohsaka M, Yamamoto K, Sawada H.
    PLoS One; 2013 Nov 15; 8(4):e61066. PubMed ID: 23613784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.